跳至主要内容
临床试验/NCT06711575
NCT06711575招募中不适用

Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections

Shandong University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年10月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
Clearance (L/h)

研究概览

简要总结

The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy.

排除标准

  • Pregnant/lactating women.
  • There are other factors that the researchers think are not suitable for inclusion

结局指标

主要结局

Clearance (L/h)

时间窗: Through study completion, an average of 30 days

Volume of Distribution (L)

时间窗: Through study completion, an average of 30 days

次要结局

  • the ratio of the area under the concentration-time curve from 0 to 24 hours(Through study completion, an average of 30 days)
  • erythrocyte sedimentation rate(Through study completion, an average of 30 days)
  • Adverse events(Through study completion, an average of 30 days)

研究者

发起方
Shandong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Zhao

Head of department of clinical pharmacy and pharmacology

Shandong University

研究点 (1)

Loading locations...

相似试验